课题基金 / 基金详情

Psilocybin Assisted Therapy (PAT) for Treatment Resistant Depression in Bipolar II Disorder (TRD.BD-II): A Randomized Controlled Trial

Psilocybin Assisted Therapy (PAT) for Treatment Resistant Depression in Bipolar II Disorder (TRD.BD-II): A Randomized Controlled Trial
裸盖菇素辅助治疗 (PAT) 治疗 II 型双相情感障碍 (TRD.BD-II) 中的难治性抑郁症:一项随机对照试验
批准号:
489735
负责人:
Yatham Lakshmi N
金额:
$87.43万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2026-09-01

项目摘要

项目成果

Yatham Lakshmi N的其他基金

相似基金

相关文献

中文摘要
翻译
摘要:双相情感障碍(BD II)是一种以情绪波动为特征的终身疾病,称为轻躁狂和抑郁发作。全世界大约每100人中就有1人患有双相障碍,并且双相障碍对男性和女性的个人生活都有重大影响
英文摘要
Lay Abstract: Bipolar II Disorder (BD II) is a lifelong condition characterized by mood fluctuations called hypomanic and depressive episodes. BD affects approximately 1 in 100 people worldwide and has a significant impact on both the personal lives of pa
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
  • 批准号:
    444068
  • 项目类别:
    Operating Grants
  • 资助金额:
    $170.53万
  • 财政年份:
    2021
  • 负责人:
    Yatham Lakshmi N
  • 依托单位:
Brain Imaging Studies of Oxidative Stress Cascade in Bipolar Disorder
  • 批准号:
    189906
  • 项目类别:
    Operating Grants
  • 资助金额:
    $20.32万
  • 财政年份:
    2009
  • 负责人:
    Yatham Lakshmi N
  • 依托单位:
Mood Stabilizer Plus Antidepressant versus Mood Stabilizer Plus Placebo in the Maintenance Treatment of Bipolar Disorder
  • 批准号:
    170712
  • 项目类别:
    Randomized Controlled Trials
  • 资助金额:
    $105.68万
  • 财政年份:
    2008
  • 负责人:
    Yatham Lakshmi N
  • 依托单位:
海外基金